Select a medication above to begin.
hydrocodone/ homatropine
generic
Black Box Warnings .
Addiction, Abuse, and Misuse
Schedule II controlled substance combination containing an opioid agonist w/ risk of addiction, abuse, and misuse, which can lead to overdose and death; reserve for use in adult pts w/ adequate assessment of cough etiology for whom benefits of cough suppression outweigh risks; assess opioid abuse or addiction risk prior to prescribing; prescribe for shortest duration consistent w/ tx goals and only refill after reevaluation of need for continued tx; regularly reassess all pts for misuse, abuse, and addiction
Respiratory Depression
serious, life-threatening, or fatal cases may occur; monitor for resp. depression, esp. during tx initiation or in high risk pts
Accidental Ingestion
accidental ingestion of even one dose, esp. by children, can result in fatal hydrocodone overdose
Medication Error Risk
ensure accuracy when prescribing, dispensing, and administering; dosing errors can result in accidental overdose and death; always use accurate mL measuring device when measuring and administering oral liquid forms
CYP450 Interactions
concomitant use w/ CYP450 3A4 inhibitors or D/C of concomitant CYP450 3A4 inducers may incr. hydrocodone conc. which may incr. or prolong adverse effects incl. potentially fatal resp. depression; monitor pts receiving any concomitant CYP450 3A4 inhibitor or inducer
Risks from Concomitant Use w/ Benzodiazepines, CNS Depressants
concomitant opioid use w/ benzodiazepines or other CNS depressants, incl. alcohol, may result in profound sedation, resp. depression, coma, and death; avoid use of opioid cough medications in pts taking benzodiazepines, other CNS depressants, or alcohol
Avoid Alcohol
instruct pts not to consume alcoholic beverages or use alcohol-containing prescription or non-prescription medications; alcohol consumption during tx may result in incr. plasma levels and potentially fatal hydrocodone overdose
Neonatal Opioid Withdrawal Syndrome
use not recommended in pregnant pts; extended use in pregnant pts can lead to potentially life-threatening neonatal opioid withdrawal syndrome; advise pregnant pts of risks and ensure tx by neonatology experts avail. at delivery if extended opioid use required
Adult Dosing .
Dosage forms: TAB: 5 mg/1.5 mg; SOL: 5 mg/1.5 mg per 5 mL
cough
- [1 tab PO q4-6h prn]
- Max: 6 tabs/day, 30 mL/day; Alt: 5 mL PO q4-6h prn; Info: use lowest effective dose, shortest effective tx duration; taper dose by 25-50% q2-4 days to D/C if prolonged use
renal dosing
- [see below]
- mild-moderate impairment: no adjustment; severe impairment: not defined, caution advised
- HD/PD: not defined
hepatic dosing
- [see below]
- mild-moderate impairment: not defined; severe impairment: not defined, caution advised
Peds Dosing .
Peds dosing is currently unavailable or not applicable for this drug.